임상 검사 서비스 시장 : 어세이 유형별, 장소별, 제품별, 국가별 예측을 포함한 전략과 동향 - 경영진 및 컨설턴트용 가이드 포함 상황 분석(2026-2030년) - 제9판

Report Overview:

Clinical laboratory testing services represent a foundational component of modern healthcare, providing diagnostic information used to detect disease, guide treatment decisions, and monitor patient health. Laboratory testing supports management of a wide range of medical conditions including cardiovascular disease, diabetes, cancer, infectious diseases, autoimmune disorders, kidney disease, and metabolic conditions. Clinical laboratory services include a broad array of test categories such as clinical chemistry, hematology, immunoassays, microbiology, molecular diagnostics, genetic testing, toxicology, and anatomic pathology.

The global Clinical Laboratory Testing Services market is estimated to be USD 203.1 billion in 2025 and is expected to grow at compound annual growth rates of 8.8% through to 2030 when it will reach USD 310.2 Billion. Growth is driven by demographic trends including aging populations, increasing prevalence of chronic diseases, expanding access to healthcare services, and growing emphasis on preventive medicine and early disease detection.

Laboratory testing plays an important role in healthcare decision-making. Clinical laboratory results are frequently used to confirm diagnoses, evaluate disease progression, assess treatment effectiveness, and monitor patient safety. As healthcare systems increasingly emphasize evidence-based medicine, demand for laboratory testing services continues to increase.

Scope of Laboratory Testing Services

Clinical laboratory services encompass a wide range of testing categories.

Clinical chemistry tests measure levels of biomarkers in blood and other body fluids to evaluate organ function and metabolic health. Examples include glucose testing, lipid panels, liver function tests, kidney function tests, and electrolyte measurements.

Hematology tests evaluate blood cells and coagulation parameters. Complete blood count (CBC) tests represent one of the most commonly ordered laboratory tests.

Immunoassays detect proteins, hormones, antibodies, and other analytes using antigen-antibody binding reactions. Immunoassay testing is widely used in endocrinology, infectious disease testing, and cancer biomarker analysis.

Microbiology testing detects bacterial, viral, fungal, and parasitic pathogens using culture methods, antigen detection, and molecular techniques.

Molecular diagnostics detect nucleic acid sequences associated with disease, enabling highly sensitive detection of infectious diseases and genetic abnormalities.

Genetic testing evaluates inherited variations associated with disease risk or treatment response.

Anatomic pathology involves examination of tissue samples to diagnose cancer and other diseases.

Toxicology testing detects drugs, environmental toxins, and other substances.

Market Structure

Clinical laboratory testing services are delivered through multiple types of providers including hospital-based laboratories, independent reference laboratories, physician office laboratories, academic medical centers, and public health laboratories.

Hospital laboratories perform testing to support inpatient and outpatient clinical care. Many hospitals also provide outreach testing services to physician offices and other healthcare providers.

Independent reference laboratories perform large volumes of testing from multiple healthcare providers and often operate centralized testing facilities supported by logistics networks for specimen transport.

Physician office laboratories perform routine tests within medical practices.

Public health laboratories perform testing related to disease surveillance and outbreak monitoring.

Reference laboratories often offer extensive test menus and specialized testing capabilities.

Laboratory networks often operate multiple testing facilities to support geographic coverage and optimize turnaround time.

Market Drivers

Several factors are driving growth in the clinical laboratory testing services market.

Aging populations are increasing demand for diagnostic testing due to higher prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer.

Increasing use of preventive healthcare services is supporting demand for routine laboratory testing.

Expansion of personalized medicine is increasing use of specialized laboratory tests such as molecular diagnostics and genetic testing.

Growth in chronic disease prevalence is increasing demand for ongoing patient monitoring.

Advances in diagnostic technologies are enabling development of new laboratory tests.

Increased healthcare access in emerging markets is supporting growth in testing volumes.

Clinical guidelines increasingly recommend laboratory testing for disease management.

Expansion of health insurance coverage in many regions supports access to laboratory services.

Technology Trends

Technological innovation is improving efficiency and expanding test menus within clinical laboratories.

Automation of sample processing and analytical workflows is improving throughput and reducing turnaround time.

Molecular diagnostics technologies are expanding the range of conditions that can be diagnosed using laboratory testing.

Digital pathology technologies enable remote analysis of tissue samples and improved collaboration among pathologists.

Laboratory information systems improve management of test data and integration with electronic health records.

Point-of-care testing technologies are expanding access to diagnostic testing outside traditional laboratory settings.

Artificial intelligence tools are being developed to assist interpretation of diagnostic results.

Automation is reducing manual processing steps and improving reproducibility.

Integration of robotics and advanced instrumentation is improving laboratory efficiency.

Market Segmentation

The clinical laboratory testing services market can be segmented by test type, service provider, end user, and geographic region.

By test type, clinical chemistry and hematology represent high-volume segments. Molecular diagnostics and genetic testing represent rapidly growing segments due to increasing use of precision medicine approaches.

By service provider, hospital laboratories and independent reference laboratories represent major segments.

End users include hospitals, physician offices, outpatient clinics, and public health agencies.

North America represents the largest regional market due to high healthcare spending and advanced diagnostic infrastructure.

Europe represents a significant market supported by established healthcare systems.

Asia-Pacific markets are expanding due to increasing investment in healthcare infrastructure.

Emerging markets represent potential growth opportunities as access to diagnostic services improves.

Competitive Landscape

The clinical laboratory testing services market includes large national laboratory networks, regional laboratories, hospital laboratories, and specialized diagnostic service providers.

Competition is influenced by pricing, turnaround time, geographic coverage, and breadth of test menu.

Large laboratory networks may benefit from economies of scale and centralized testing facilities.

Strategic partnerships between laboratories and healthcare providers may influence market share.

Integration of advanced diagnostic technologies may provide competitive advantages.

Service quality and reliability are important factors in laboratory selection.

Logistics capabilities play an important role in specimen transport.

Laboratories are increasingly investing in digital infrastructure and automation technologies.

Future Outlook

The clinical laboratory testing services market is expected to continue expanding as demand for diagnostic testing increases.

Growth in molecular diagnostics and genetic testing may expand the role of laboratory services in personalized medicine.

Automation technologies may improve efficiency and reduce cost per test.

Expansion of point-of-care testing may complement centralized laboratory services.

Artificial intelligence tools may improve interpretation of laboratory data.

Population health management initiatives may increase use of laboratory testing for preventive care.

Overall, clinical laboratory testing services represent a critical component of healthcare delivery. Continued advances in diagnostic technologies, automation, and data analytics are expected to support steady long-term market growth.

Table of Contents

1 Market Guides

• 1.1 Strategic Situation Analysis
  • 1.1.1 Role in Healthcare Delivery
  • 1.1.2 Pricing Pressure and Reimbursement Constraints
  • 1.1.3 Market Consolidation and Competitive Landscape
  • 1.1.4 Workforce Shortages and Operational Challenges
  • 1.1.5 Technological Innovation and Digital Transformation
  • 1.1.6 Expansion of Molecular and Genetic Testing
  • 1.1.7 Regulatory and Quality Requirements
  • 1.1.8 Logistics and Sample Management Challenges
  • 1.1.9 Geographic Market Dynamics
  • 1.1.10 Outlook and Strategic Implications
• 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3 Guide for Management Consultants and Investment Advisors
• 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

• 2.1 The New Demand for Clinical Testing
• 2.2 Defining the Opportunity
  • 2.2.1 Revenue Market Size
• 2.3 Methodology
  • 2.3.1 Methodology
  • 2.3.2 Sources
  • 2.3.3 Authors
• 2.4 Perspective: Healthcare and the IVD Industry
  • 2.4.1 Global Healthcare Spending
  • 2.4.2 Spending on Diagnostics
  • 2.4.3 Important Role of Insurance for Diagnostics

3 Overview of a Dynamic Market

• 3.1 Players in a Dynamic Market
  • 3.1.1 Academic Research Lab
  • 3.1.2 Diagnostic Test Developer
  • 3.1.3 Instrumentation Supplier
  • 3.1.4 Chemical/Reagent Supplier
  • 3.1.5 Pathology Supplier
  • 3.1.6 Independent Clinical Laboratory
  • 3.1.7 Public National/regional Laboratory
  • 3.1.8 Hospital Laboratory
  • 3.1.9 Physicians Office Lab (POLS)
  • 3.1.10 Audit Body
  • 3.1.11 Certification Body
• 3.2 Segmentation - Different Approaches
  • 3.2.1 Traditional Market Segmentation
  • 3.2.2 Laboratory Focus and Segmentation
• 3.3 Structure of Clinical Testing Industry
  • 3.3.1 The Hospital Lab - Share of the Pie
  • 3.3.2 Key Role for Economies of Scale
  • 3.3.3 Physician Office Lab's are Still Here
  • 3.3.4 Physician's and POCT - Reviving Patient Service in China
• 3.4 National and Regional Diversity

4 Trends Driving a Changing Market

• 4.1 Growth Is Pushed from Many Sides
  • 4.1.1 Demographic Impacts on Consumption
  • 4.1.2 COVID Related Impacts
  • 4.1.3 Point of Care Testing Makes a Difference
  • 4.1.4 Alternative Medicine Effect
  • 4.1.5 Esoterics
  • 4.1.6 A New Laboratory Discipline
• 4.2 Factors at Work to Shrink the Market
  • 4.2.1 Where are Costs Going?
  • 4.2.2 Population Effects
  • 4.2.3 Management Practices
  • 4.2.4 Wellness
  • 4.2.5 Cannabilization
  • 4.2.6 Point of Care
• 4.3 Automation and Laboratory Trends
  • 4.3.1 Traditional Automation and Centralization
  • 4.3.2 The New Automation, Decentralization and Point Of Care
  • 4.3.3 Instruments Key to Market Share
  • 4.3.4 Bioinformatics Plays a Role
  • 4.3.5 PCR Takes Command
  • 4.3.6 Next Generation Sequencing Fuels a Revolution
  • 4.3.7 NGS Impact on Pricing
  • 4.3.8 Whole Genome Sequencing, A Brave New World
  • 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.3.10 Shifting Role of Diagnostics

5 Clinical Laboratory Services Recent Developments

• 5.1 Recent Developments - Importance and How to Use This Section
  • 5.1.1 Importance of These Developments
  • 5.1.2 How to Use This Section
• 5.2 Source Bioscience Acquires Cambridge Clinical Labs
• 5.3 Labcorp Acquires Select Assets of BioReference Health
• 5.4 hc1 + Accumen Launches Clinical Excellence Solutions
• 5.5 Labcorp enters lab management, services agreement with Inspira Health
• 5.6 Aventa Genomics Receives Favorable Pricing Determination
• 5.7 Perseus Completes Acquisition of Matrix Sistemas e Servicos Ltda
• 5.8 Delve Bio Announces Partnership with Broad Clinical Labs for mNGS
• 5.9 Quest Dx to Acquire Select Lab Assets from Allina Health
• 5.10 Eurofins buys Ascend Clinical LLC
• 5.11 Atalan Sees Potential in Hospital Outreach Business
• 5.12 Challenge Bringing Routine Testing to Point of Care
• 5.13 Natera Cites Test Volume Growth, Rosy Reimbursement
• 5.14 Patients Becoming Stakeholders in Infectious Disease Testing
• 5.15 MedGenome Acquires Prognosis Laboratories
• 5.16 Brooks Automation acquires Aim Lab
• 5.17 Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
• 5.18 Mayo Clinic Laboratories and Helix to provide Biopharma Services
• 5.19 CompuGroup Medical acquires Medicus Laboratory Information Systems
• 5.20 Quest Diagnostics acquires Summa Health outreach lab
• 5.21 Q2 Solutions Launches Self-Collection Safety Lab Panel
• 5.22 Bionano Genomics Announces Launch of Bionano Laboratories
• 5.23 Labcorp to Spin Off Clinical Development Business
• 5.24 Value-Based Care Growing More Profitable for Labs
• 5.25 Lucid Diagnostics Reports Revenue Growth
• 5.26 NGS Cancer Testing Decision Appeases Industry
• 5.27 Clinical Labs Make Strong Showing in 2021
• 5.28 Seegene to Enter Syndromic MDx Space
• 5.29 EKF Diagnostics Acquires Advanced Diagnostic Laboratory
• 5.30 Molecular Health, EDGC Ink Liquid Biopsy Partnership
• 5.31 ProPhase Labs Acquires Nebula Genomics for $14.6M
• 5.32 Karius Cell-Free DNA Method to Detect Infection Validated
• 5.33 EDGC Enters Liquid Biopsy Space With Cf DNA
• 5.34 TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
• 5.35 Enzo Biochem Q2 Revenues Up 62 Percent
• 5.36 Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
• 5.37 FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
• 5.38 Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
• 5.39 Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
• 5.40 Cooperative Aims to Expand Clinical, Commercial NGS Access

6 Profiles of Key Companies

• 6.1 Accel Diagnostics
• 6.2 Acibadem Labmed Laboratory
• 6.3 ACM Medical Laboratory
• 6.4 Adicon Clinical Laboratories
• 6.5 Aegis Science Corporation
• 6.6 American Bio-Clinical Laboratories, Int'l
• 6.7 ARUP Laboratories
• 6.8 Ascend Clinical
• 6.9 Bio-Reference Laboratories
• 6.10 Bioscientia Institut fur Medizinische Diagnostik GmbH
• 6.11 BP Healthcare Group
• 6.12 C2N Diagnostics
• 6.13 Clinical Reference Laboratory
• 6.14 Clongen Laboratories
• 6.15 CompuNet Clinical Laboratories
• 6.16 DASA
• 6.17 DIAN Diagnostics Co., Ltd.
• 6.18 Enzo Biochem
• 6.19 Eone Laboratories
• 6.20 Eurofins Scientific
• 6.21 Exagen Diagnostics
• 6.22 Flow Health
• 6.23 Fyr Diagnostics
• 6.24 Genzyme Corporation
• 6.25 Guangzhou Kingmed Diagnostics Group Co., Ltd.
• 6.26 Haystack Oncology (Quest Dx)
• 6.27 Innoquest Pathology
• 6.28 Integrated Regional Laboratories
• 6.29 KDL Group
• 6.30 Laboratory Corporation of America
• 6.31 Lifelabs (Quest)
• 6.32 Mayo Clinic Laboratories
• 6.33 Medicover
• 6.34 Myriad Genetics
• 6.35 NeoGenomics
• 6.36 OncoDNA
• 6.37 Oncohost
• 6.38 Prometheus Laboratories
• 6.39 ProPhase Labs
• 6.40 Psychemedics Corporation
• 6.41 Quest Diagnostics
• 6.42 SkylineDx
• 6.43 Sonic Healthcare
• 6.44 Sophia Genetics
• 6.45 Spectra Laboratories
• 6.46 Streamline Scientific
• 6.47 Synlab
• 6.48 -Sysmex Inostics
• 6.49 Unilabs
• 6.50 Werfen

7 The Global Market for Clinical Laboratory Testing

• 7.1 Global Market Overview by Country
  • 7.1.1 Table - Global Market by Country
  • 7.1.2 Chart - Global Market by Country
• 7.2 Global Market by Assay Type - Overview
  • 7.2.1 Table - Global Market by Assay Type
  • 7.2.2 Chart - Global Market by Assay Type - Base/Final Year Comparison
  • 7.2.3 Chart - Global Market by Assay Type - Base Year
  • 7.2.4 Chart - Global Market by Assay Type - End Year
  • 7.2.5 Chart - Global Market by Assay Type - Share by Year
  • 7.2.6 Chart - Global Market by Assay Type - Segments Growth
• 7.3 Global Market by Place - Overview
  • 7.3.1 Table - Global Market by Place
  • 7.3.2 Chart - Global Market by Place - Base/Final Year Comparison
  • 7.3.3 Chart - Global Market by Place - Base Year
  • 7.3.4 Chart - Global Market by Place - End Year
  • 7.3.5 Chart - Global Market by Place - Share by Year
  • 7.3.6 Chart - Global Market by Place - Segments Growth
• 7.4 Global Market by Product - Overview
  • 7.4.1 Table - Global Market by Product
  • 7.4.2 Chart - Global Market by Product - Base/Final Year Comparison
  • 7.4.3 Chart - Global Market by Product - Base Year
  • 7.4.4 Chart - Global Market by Product - End Year
  • 7.4.5 Chart - Global Market by Product - Share by Year
  • 7.4.6 Chart - Global Market by Product - Segments Growth

8 Global Clinical Laboratory Diagnostic Markets - By Assay Type

• 8.1 Chemistry
  • 8.1.1 Table Chemistry - by Country
  • 8.1.2 Chart - Chemistry Growth
• 8.2 Microbiology
  • 8.2.1 Table Microbiology - by Country
  • 8.2.2 Chart - Microbiology Growth
• 8.3 Hematology
  • 8.3.1 Table Hematology - by Country
  • 8.3.2 Chart - Hematology Growth
• 8.4 Anatomic Pathology
  • 8.4.1 Table Anatomic Pathology - by Country
  • 8.4.2 Chart - Anatomic Pathology Growth
• 8.5 Molecular Diagnostics
  • 8.5.1 Table Molecular Diagnostics - by Country
  • 8.5.2 Chart - Molecular Diagnostics Growth
• 8.6 Esoteric
  • 8.6.1 Table Esoteric - by Country
  • 8.6.2 Chart - Esoteric Growth

9 Global Clinical Laboratory Diagnostic Markets - By Place

• 9.1 In Patient Hospital
  • 9.1.1 Table In Patient Hospital - by Country
  • 9.1.2 Chart - In Patient Hospital Growth
• 9.2 Out Patient Hospital
  • 9.2.1 Table Out Patient Hospital - by Country
  • 9.2.2 Chart - Out Patient Hospital Growth
• 9.3 Independent Laboratory
  • 9.3.1 Table Independent Laboratory - by Country
  • 9.3.2 Chart - Independent Laboratory Growth
• 9.4 Physicians Office Laboratory
  • 9.4.1 Table Physicians Office Laboratory - by Country
  • 9.4.2 Chart - Physicians Office Laboratory Growth
• 9.5 Other Laboratory
  • 9.5.1 Table Other Laboratory - by Country
  • 9.5.2 Chart - Other Laboratory Growth

10 Global Clinical Laboratory Diagnostic Markets - By Product

• 10.1 Instruments
  • 10.1.1 Table Instruments - by Country
  • 10.1.2 Chart - Instruments Growth
• 10.2 Reagents
  • 10.2.1 Table Reagents - by Country
  • 10.2.2 Chart - Reagents Growth
• 10.3 Labour
  • 10.3.1 Table Labour - by Country
  • 10.3.2 Chart - Labour Growth
• 10.4 Overhead
  • 10.4.1 Table Overhead - by Country
  • 10.4.2 Chart - Overhead Growth
• 10.5 Other Product
  • 10.5.1 Table Other Product - by Country
  • 10.5.2 Chart - Other Product Growth

11 The Future of the Clinical Laboratory

12 Appendices

• 12.1 United States Medicare System: Clinical Laboratory Fees Schedule
• 12.2 The Most Used IVD Assays
• 12.3 The Highest Grossing Assays

Table of Tables

• Table 1 Market Players by Type
• Table 2 Clinical Laboratory Departments and Segments
• Table 3 Laboratory Management Focus - Different Approaches
• Table 4 Key Segmentation Variables Going Forward
• Table 5 Factors Affecting Local Clinical Testing Demand
• Table 6 Seven Factors Driving Growth
• Table 7 Alternative Medicine Segments
• Table 8 Six Factors Limiting Growth
• Table 9 Seven Key Diagnostic Laboratory Technology Trends
• Table 10 - Global Market by Region
• Table 11 Global Market by Assay Type
• Table 12 Global Market by Place
• Table 13 Global Market by Product
• Table 14 Chemistry by Country
• Table 15 Microbiology by Country
• Table 16 Hematology by Country
• Table 17 Anatomic Pathology by Country
• Table 18 Molecular Diagnostics by Country
• Table 19 Esoteric by Country
• Table 20 In Patient Hospital by Country
• Table 21 Out Patient Hospital by Country
• Table 22 Independent Laboratory by Country
• Table 23 Physicians Office Laboratory by Country
• Table 24 Other Laboratory by Country
• Table 25 Instruments by Country
• Table 26 Reagents by Country
• Table 27 Labour by Country
• Table 28 Overhead by Country
• Table 29 Other Product by Country
• Table 30 Clinical Lab Fee Schedule
• Table 31 The Most Common Assays
• Table 32 Largest Revenue Assays

Table of Figures

• Figure 1 Global Healthcare Spending
• Figure 2 The Road to Diagnostics
• Figure 3 The Changing Age of The World's Population
• Figure 4 Health Care Consumption by Age
• Figure 5 Cancer Incidence - Age at Diagnosis
• Figure 6 Centralized vs. Decentralized Laboratory Service
• Figure 7 A Highly Multiplexed Syndromic Testing Unit
• Figure 8 The Real Cost to Sequence the Human Genome
• Figure 9 The Codevelopment Process
• Figure 10 Comparing MDx Diagnostic and Traditional Testing
• Figure 11 Global Market Pareto Chart
• Figure 12 Global Market by Assay Type - Base vs. Final
• Figure 13 Global Market by Assay Type Base Year
• Figure 14 Global Market by Assay Type End Year
• Figure 15 Assay Type Share by Year
• Figure 16 Assay Type Segments Growth
• Figure 17 Global Market by Place - Base vs. Final
• Figure 18 Global Market by Place Base Year
• Figure 19 Global Market by Place End Year
• Figure 20 Place Share by Year
• Figure 21 Place Segments Growth
• Figure 22 Global Market by Product - Base vs. Final
• Figure 23 Global Market by Product Base Year
• Figure 24 Global Market by Product End Year
• Figure 25 Product Share by Year
• Figure 26 Product Segments Growth
• Figure 27 Chemistry Growth
• Figure 28 Microbiology Growth
• Figure 29 Hematology Growth
• Figure 30 Anatomic Pathology Growth
• Figure 31 Molecular Diagnostics Growth
• Figure 32 Esoteric Growth
• Figure 33 In Patient Hospital Growth
• Figure 34 Out Patient Hospital Growth
• Figure 35 Independent Laboratory Growth
• Figure 36 Physicians Office Laboratory Growth
• Figure 37 Other Laboratory Growth
• Figure 38 Instruments Growth
• Figure 39 Reagents Growth
• Figure 40 Labour Growth
• Figure 41 Overhead Growth
• Figure 42 Other Product Growth